autologous humanized anti-cd19 and anti-cd20 dual specific car-t cells

Cell therapyexperimental

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06879262Early Phase 1 (Phase 1)Mar 15, 2025Huazhong University of Science and Technology
NCT06160362N/AOct 31, 2023Henan Medical University
NCT04486872Phase 1Jul 25, 2020Zhejiang University
NCT04186520Phase 1/Phase 2 (Phase 2)Feb 1, 2020Medical College of Wisconsin
NCT04215016Phase 1Dec 31, 2019Fujian Medical University
NCT04049383Phase 1Oct 1, 2019Medical College of Wisconsin, University of Wisconsin
NCT03271515Phase 1Oct 1, 2017Beijing Doing Biomedical Co., Ltd.
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Medical College of WisconsinAcademic/Hospital2222019
Beijing Doing Biomedical Co., Ltd.For profit1112017
Fujian Medical UniversityAcademic/Hospital1112019
Henan Medical UniversityAcademic/Hospital1112023
Huazhong University of Science and TechnologyAcademic/Hospital1112025
University of WisconsinAcademic/Hospital1012019
Zhejiang UniversityAcademic/Hospital1112020
7 organizations
Page 1 / 1